Related references
Note: Only part of the references are listed.Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Jesus Rodriguez-Bano et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-β-lactamase-producing Enterobacteriaceae in France
Muriel Galas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Factors associated with multidrug-resistant bacteria in secondary peritonitis:: impact on antibiotic therapy
P. Seguin et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide:: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)
Flavia Rossi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Candida as a risk factor for mortality in peritonitis
P Montravers et al.
CRITICAL CARE MEDICINE (2006)
Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs
MCJM Sturkenboom et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide:: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)
DL Paterson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
European recommendations for antimicrobial resistance surveillance
G Cornaglia et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Clinical and therapeutic features of non postoperative nosocomial intra-abdominal infections
P Montravers et al.
ANNALS OF SURGERY (2004)
Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections
JS Solomkin et al.
CLINICAL INFECTIOUS DISEASES (2003)
Cost of care for inpatients with community-acquired intra-abdominal infections
P Cattan et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2002)
Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis
A Sotto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis
A Sitges-Serra et al.
BRITISH JOURNAL OF SURGERY (2002)
The microbiology of postoperative peritonitis
A Roehrborn et al.
CLINICAL INFECTIOUS DISEASES (2001)
Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial
H Dupont et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
